Seven quinolone antibiotics were tested against 115 isolates of methicillin-resistant Staphylococcus aureus. The MICs for 90% of the strains tested were 0.5 ,ug/ml for A-56619, A-56620, ciprofloxacin, and ofloxacin; 2.0 ,ug/ml for amifloxacin and enoxacin; and 4.0 ,ug/ml for norfloxacin. Killing kinetic studies showed a similar killing rate for all seven antibiotics.
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Methicillin-resistant Staphylococcus aureus (MRSA) has become a major pathogen in patients who are intravenous drug abusers and in patients who have nosocomially acquired infections, and it has also become a major colonizing organism in health care workers (7, 10, 16 The results of susceptibility testing for 115 strains of MRSA are shown in Table The results of killing kinetic studies are shown in Table 2 .
When an initial inoculum of 5 x 105 CFU/ml and an antibiotic concentration of five times the MIC were used, the rates of bacterial killing by the seven quinolones did not differ significantly. After (2, 4, 9, 14) . Of all the quinolones evaluated against MRSA in this study, A-56619, A-56620, ciprofloxacin, and ofloxacin inhibited growth at lower concentrations that did the other three quinolones; however, all agents were effectively bactericidal. Determination of the usefulness of each of these agents in the treatment of colonization or infections caused by MRSA must await the results of clinical studies, which should be designed with the present data in mind.
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